BMC Medical Co., Ltd. (SHE:301367)
China
· Delayed Price · Currency is CNY 73.08
+1.50 (2.10%)
At close: Apr 30, 2025, 2:57 PM CST
BMC Medical Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| Net Income | 177.4 | 155.38 | 297.34 | 380.3 | 145.68 | 227.86 | Upgrade
|
| Depreciation & Amortization | 21.04 | 21.04 | 19.4 | 8.74 | 8.81 | 1.87 | Upgrade
|
| Other Amortization | 5.79 | 5.79 | 3.93 | 2.29 | 1.78 | 1.91 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.19 | -0.19 | -0.48 | -0.02 | - | -0.05 | Upgrade
|
| Asset Writedown & Restructuring Costs | 3.06 | 3.06 | 0.02 | 3.77 | 0.25 | -2 | Upgrade
|
| Loss (Gain) From Sale of Investments | -49.93 | -60.36 | -57.17 | -14.82 | -8.46 | -6.96 | Upgrade
|
| Provision & Write-off of Bad Debts | 2.75 | 2.75 | 2.8 | - | - | - | Upgrade
|
| Other Operating Activities | -52.41 | 13.96 | 13.97 | -10.78 | 3.87 | 2.96 | Upgrade
|
| Change in Accounts Receivable | -67.95 | -67.95 | -21.97 | -63.53 | -19.68 | 12.55 | Upgrade
|
| Change in Inventory | 2.86 | 2.86 | 75.06 | -86.08 | -69.78 | -20.13 | Upgrade
|
| Change in Accounts Payable | 80.68 | 80.68 | -183.63 | 158.51 | 42.54 | 41.32 | Upgrade
|
| Change in Other Net Operating Assets | - | - | - | - | - | 3.8 | Upgrade
|
| Operating Cash Flow | 120.16 | 154.08 | 151.11 | 375.21 | 104.4 | 267.41 | Upgrade
|
| Operating Cash Flow Growth | -20.18% | 1.97% | -59.73% | 259.39% | -60.96% | 638.51% | Upgrade
|
| Capital Expenditures | -15.79 | -15.93 | -24.12 | -23.75 | -10.03 | -15.43 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.3 | 0.48 | 0.16 | 0.08 | 0 | 5.65 | Upgrade
|
| Cash Acquisitions | - | - | - | 5.86 | - | - | Upgrade
|
| Investment in Securities | 114.24 | -604.87 | 268.44 | -1,859 | -164.85 | -63 | Upgrade
|
| Other Investing Activities | 9.01 | 19.21 | 57.43 | 1 | - | 5.95 | Upgrade
|
| Investing Cash Flow | 107.76 | -601.1 | 301.9 | -1,876 | -174.87 | -66.83 | Upgrade
|
| Short-Term Debt Issued | - | 384.49 | - | - | - | - | Upgrade
|
| Total Debt Issued | 533.49 | 384.49 | - | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -11.44 | -9.76 | -3.12 | -1.38 | - | Upgrade
|
| Total Debt Repaid | -210.24 | -11.44 | -9.76 | -3.12 | -1.38 | - | Upgrade
|
| Net Debt Issued (Repaid) | 323.25 | 373.05 | -9.76 | -3.12 | -1.38 | - | Upgrade
|
| Issuance of Common Stock | - | - | - | 1,764 | - | 0.23 | Upgrade
|
| Common Dividends Paid | -67.05 | -65.79 | -128 | - | -28.8 | -12.05 | Upgrade
|
| Other Financing Activities | -83.72 | -67.33 | -2 | -25.86 | - | - | Upgrade
|
| Financing Cash Flow | 172.48 | 239.93 | -139.76 | 1,735 | -30.18 | -11.81 | Upgrade
|
| Foreign Exchange Rate Adjustments | 12.11 | 4.36 | -0.41 | 7.59 | -3.67 | -2.96 | Upgrade
|
| Net Cash Flow | 412.52 | -202.73 | 312.84 | 241.89 | -104.32 | 185.81 | Upgrade
|
| Free Cash Flow | 104.37 | 138.16 | 126.98 | 351.46 | 94.38 | 251.99 | Upgrade
|
| Free Cash Flow Growth | -19.06% | 8.80% | -63.87% | 272.41% | -62.55% | 708.54% | Upgrade
|
| Free Cash Flow Margin | 11.39% | 16.38% | 11.31% | 24.83% | 14.24% | 44.96% | Upgrade
|
| Free Cash Flow Per Share | 1.17 | 1.55 | 1.42 | 4.96 | 1.41 | 3.75 | Upgrade
|
| Cash Income Tax Paid | - | 3.49 | -5.79 | -77.83 | 2.23 | 39.9 | Upgrade
|
| Levered Free Cash Flow | 111.85 | 94.07 | 44.8 | 242.34 | 49.67 | 189.9 | Upgrade
|
| Unlevered Free Cash Flow | 113.63 | 95.85 | 45.65 | 242.63 | 49.8 | 189.9 | Upgrade
|
| Change in Net Working Capital | -30.93 | -24.34 | 118.87 | -6.46 | 44.82 | -34.79 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.